Ozanimod Oral Capsule

DRUG2 trials

Sponsors

I.R.C.C.S. Fondazione Santa Lucia, Geert D'Haens

Conditions

Multiple SclerosisUlcerative Colitis

Phase 4

Multidimensional Integrated Assessment to Test the Efficacy and Response to Ozanimod in Multiple Sclerosis.

TerminatedNCT05777902

I.R.C.C.S. Fondazione Santa LuciaMultiple Sclerosis

Start: 2023-01-31End: 2024-04-11Updated: 2025-01-15

Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ Study

WithdrawnNCT06188637

Geert D'HaensUlcerative Colitis

Start: 2024-08-01End: 2027-03-01Updated: 2024-09-19